Accordingly, in vivo downregulation of mGluR1 or mGluR5 in the SOD1G93A mouse model of ALS delayed the disease onset, slowed the disease progression, and prolonged survival. The gene discussed is GRM5; the disease is amyotrophic lateral sclerosis.